Title : Aldo-keto reductase 1C3 is overexpressed in skin squamous cell carcinoma (SCC) and affects SCC growth via prostaglandin metabolism.

Pub. Date : 2014 Aug

PMID : 24917395






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 It metabolizes PGD2 to 9alpha11beta-PGF2 , diverting the spontaneous conversion of PGD2 to the PPARgamma agonist, 15-Deoxy-Delta-12, 14-prostaglandin J2 (15d-PGJ2 ). 15-deoxy-delta(12,14)-prostaglandin J2 peroxisome proliferator activated receptor gamma Mus musculus
2 It metabolizes PGD2 to 9alpha11beta-PGF2 , diverting the spontaneous conversion of PGD2 to the PPARgamma agonist, 15-Deoxy-Delta-12, 14-prostaglandin J2 (15d-PGJ2 ). 15-deoxy-delta(12,14)-prostaglandin J2 peroxisome proliferator activated receptor gamma Mus musculus
3 Although attenuating AKR1C3 expression in SCC cells by siRNA did not affect growth, treatment with PGD2 and its dehydration metabolite, 15d-PGJ2 , decreased SCC proliferation in a PPARgamma-dependent manner. 15-deoxy-delta(12,14)-prostaglandin J2 peroxisome proliferator activated receptor gamma Mus musculus
4 This work suggests that PGD2 and its metabolite 15d-PGJ2 attenuate SCC proliferation in a PPARgamma-dependent manner, therefore activation of PPARgamma by agonists such as pioglitazone may benefit those at high risk of SCC. 15-deoxy-delta(12,14)-prostaglandin J2 peroxisome proliferator activated receptor gamma Mus musculus
5 This work suggests that PGD2 and its metabolite 15d-PGJ2 attenuate SCC proliferation in a PPARgamma-dependent manner, therefore activation of PPARgamma by agonists such as pioglitazone may benefit those at high risk of SCC. 15-deoxy-delta(12,14)-prostaglandin J2 peroxisome proliferator activated receptor gamma Mus musculus